LFST
LifeStance Health Group, Inc.NASDAQHealthcare$6.31-0.94%ClosedMarket Cap: $2.46B
As of 2026-04-06
Valuation
P/E (TTM)
254.53
PEG
2.18
P/B
1.62
P/S
1.75
EV/EBITDA
30.97
DCF Value
$21.08
FCF Yield
5.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
30.4%
Operating Margin
1.7%
Net Margin
0.7%
ROE
0.7%
ROA
0.4%
ROIC
1.0%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $382.2M | 29.5% | $18.4M | $11.7M | $0.03 | — |
| FY 2025 | $1.42B | 28.5% | $25.7M | $9.7M | $0.02 | — |
| Q3 2025 | $363.8M | 32.0% | $7.4M | $1.1M | $0.00 | — |
| Q2 2025 | $345.3M | 27.3% | $-3.0M | $-3.8M | $-0.01 | — |
| Q1 2025 | $333.0M | 33.0% | $1.6M | $709.0K | $0.00 | — |
| Q4 2024 | $325.5M | 33.6% | $1.1M | $-7.1M | $-0.02 | — |
| FY 2024 | $1.25B | 32.2% | $-31.6M | $-57.4M | $-0.15 | — |
| Q3 2024 | $312.7M | 32.1% | $47.0K | $-6.0M | $-0.02 | — |
| Q2 2024 | $312.3M | 31.3% | $-15.9M | $-23.3M | $-0.06 | — |
| Q1 2024 | $300.4M | 31.5% | $-16.8M | $-21.1M | $-0.06 | — |
| Q4 2023 | $280.6M | 29.7% | $-32.3M | $-45.0M | $-0.12 | — |
| FY 2023 | $1.06B | 28.6% | $-189.1M | $-186.3M | $-0.51 | — |